[Relex® SMILE® surgery for refractive errors]
Rodriguez B, Ciapponi A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A.
Record ID 32018001524
Original Title: Cirugía Relex® SMILE® para errores de la refracción
Authors' recomendations: CONCLUSIONS Low-quality evidence suggests that, in terms of efficacy, safety and predictability, Relex® SMILE® surgery is similar to other refractive surgery techniques (photoreactive keratectomy, femtosecond laser-assisted in situ keratomileusis) in correcting myopia with or without astigmatism in adults at mid-term. Very low-quality evidence does not allow drawing conclusions about dry eye development after surgery at mid-term. No comparative evidence could be identified about the long-term clinical effectiveness of Relex® SMILE® surgery. One United States clinical practice guideline mentions that the decision to undergo refractive surgery should be individualized, and may be considered when one patient wishes to become independent from external optical aids or when there are occupational or cosmetic reasons for not using them. Most public and private sponsors consulted do not mention or cover Relex® SMILE® surgery in refractive error correction. No economic evaluations providing information about the cost-effectiveness of Relex® SMILE® surgery in Argentina have been found.
Project Status: Completed
Year Published: 2019
URL for published report: https://www.iecs.org.ar/home-ets/
English language abstract: An English language summary is available
Publication Type: Not Assigned
- Corneal Surgery, Laser
- Keratomileusis, Laser In Situ
- Lasers, Excimer
- Refraction, Ocular
Organisation Name: Institute for Clinical Effectiveness and Health Policy
Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name: firstname.lastname@example.org
Contact Email: email@example.com
Copyright: Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.